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In the past five years, 16 adults (10 females, age 25-61 years, mean 48) with giant cavernous
hemangioma of the liver measuring 15-31 cm (mean-19) underwent surgery in a single Institution.
Diagnosis was made with the help of multimodal investigations- ultrasound (US), computed tomogra-
phy (CT), hepatic angiography, hepatic scintigraphy and fine needle biopsy. Ultrasound and CT had
sensitivities of 69% and 82% respectively. Fourteen had preoperative selective hepatic artery emboliza-
tion to study its effect on operative blood loss. Indication for surgery in all cases was a large abdominal
mass with varying severity of pain. In addition, 5 had hemetological and/or coagulation abnormalities,
hemobilia in and pyrexia in 1. Seven left lobectomies, 3 left lateral segmentectomies, 2 right
lobectomies, 2 right trisegmentectomies and 4 non-anatomical resections of to 3 segments were
performed. Postoperative complications developed in 25% with no operative mortality. Preoperative
selective hepatic artery embolization helped to decrease the operative hemorrhage in 13 (mean blood
loss- 1146 ml). In two cases severe bleeding required use of Cell-saver and massive donor blood
transfusion. Our results suggest use of preoperative selective hepatic artery embolization and Cell-saver
as an adjunct to the liver resection for these vascular tumors.
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INTRODUCTION
Cavernous hemangioma of the liver was first described by Dupuytren and
Cruveilhier1. It is the most common benign hepatic neoplasm with autopsy
incidence of 0.7-7.4% 2’3. I’n the recent years, because of widespread use of
noninvasive diagnostic techniques- ultrasonography (US), computed tomography
(CT) and magnetic resonance imaging (MRI), they are detected more frequently4’5.
Natural history of the disease is vague and the role of surgery is a matter of debate’.
However, liver resection, hepatic artery ligation and in recent years hepatic artery
embolization are recommended as treatment modalities in giant cavernous heman-
giomas of the liver7-1. In this paper clinical presentation, diagnosis and surgical
treatment of 16 cases of giant cavernous hemangiomas of the liver are reviewed and
the effect of preoperative embolization on the intraoperative blood loss is studied.
PATIENTS AND METHODS
Between March 1985 and March 1990, 16 patients with giant cavernous hemangio-
mas of the liver underwent major hepatic resections at Vishnevsky Institute of
Surgery, Academy of Medical Sciences, Moscow. Our Institute is one of the major
referral centres for performing hepatic surgery in USSR. Patients with giant hepatic
hemangiomas measuring 15 cm or more in size were included in this study. US, CT,
hepatic angiography and hepatic scintigraphy were performed in all (Table 1). Fine
needle aspiration cytology was done in 11 cases to study its diagnostic accuracy.
Hepatic angiography was performed in all using standard Seldinger technique via
the right or left femoral artery and this procedure was followed by selective
embolization of the feeding vessel(s) of the lesion in 14 cases with the use of
HYDROGEL emboli. These emboli were worked out at our Institute in collabor-
ation with Institute of Macromolecular Chemistry, Czechoslovak Academy of
Sciences. In 2 cases, embolization could not be performed because of tortusity of
hepatic artery at its origin. Intraoperative ultrasound was used to define the
relations of the hemangioma with surrounding hepatic parenchymal structures thus
enabling safe resection with ultrasound scalpel (ALOKA SUS-101). In 2 cases
HAEMONETICS Cell-saver 4 was used for transfusion of the blood from the
operating field. The cut surface of liver remnant was treated by various methods-
pneumothermocoagulation, biological tissue glue and omentopexy. Fourteen
patients were followed-up for 6 to 45 months period.
Table Details of multimodality diagnostic procedures.








FNAC Fine nedle aspiration cytology
SCINTI Hepatic scintigraphy
+ 14 underwent selective hepatic artery cmbolization preoperatively.GIANT CAVERNOUS HEMANGIOMA LIVER 71
RESULTS
There were 10 females and 6 males with mean age of 48 years (range 25-61 yrs). All
were symptomatic with duration from 6 months to 9 years (mean 3.5 years).
Palpable abdominal lump and pain of varying severity or feeling of heaviness upper
abdomen were recorded in all 16 cases (Table 2). Nine had upper gastrointestinal
pressure symptoms- feeling of discomfort in right hypochondrium or epigastrium,
especially after food intake and nausea. Weakness and weight loss were recorded in
5, hemobilia in 1 and pyrexia in 1. Blood examination revealed anemia in 3,
hypofibrinogenemia in 3 and thrombocytopenia with low prothrombin time in 1.
Four patients were referred to us after laparoscopic diagnosis of the lesion and one
after cholecystectomy when a patient was found to have a giant hepatic heman-
gioma. Ultrasound examination was diagnostic in 11 with sensitivity of 69% and
showed mixed echo pattern of the lesion. CT with contrast enhancement was more
helpful in diagnosis with sensitivity of 82% (13 cases). The CT features were
hypodense area of the lesion on plain scan and progressive dense accumulation of
contrast from periphery to centre of hemangioma on IV bolous dynamic scanning
(Figures la & b). Fine needle aspiration cytology was done under US/CT in 11
cases without any complications. Cytological examination revealed presence of
endothelial cells in 7 (64%) and elements of blood only in 4. However, presence of
malignant or atypical cells was excluded in all. Selective hepatic angiography
showed typical cotton-wool appearance in all (Figure 2a). Following selective
embolization of the feeding vessel(s) of hepatic hemangioma (Figure 2b) in total of
14 cases, exacerbation of abdominal pain occured in 8, febrile reaction in 5 and
hypofibrinogenemia in 2. Patients underwent surgery 1-12 days following emboli-
zation. Hepatic scintigraphy showed nonspecific filling defect or decreased accumu-
lation of isotope in the lesion.
Table 2 Clinical features and hematological abnormalities.
Description No. of patients
CLINICAL FEATURES
Abdominal lump
Pain/Heaviness upper abdomen 16
Post praundial upper
abdominal discomfort/Nausea 9






Thrombocytopenia and low PTI
Multiple segmental involvement of liver was recognized in all, with hemangioma
affecting segments of right lobe only in 3, left lobe only in 5 and both lobes in 8
(Table 3). The size of lesion ranged from 15 to 31_ cm (mean 19). Six had additional
lesions measuring 2-8 cm. Presence of huge hepatomegaly with varying severity of
pain/discomfort in the abdomen was the indication for surgery in all. Other72 V.A. VISHNEVSKY ET AL.
Figure l(a). Plain CT scan (Case 15) showing huge hemangioma of right lobe liver with large central
blood filled cavity. (b) Early phase of dense contrast accumulation after IV boIous injection.GIANT CAVERNOUS HEMANGIOMA LIVER 73
Figure 2(a). Arterial phase of hepatic angiography showing displacement of branches and diffuse
pooling of the contrast (case 15). (b) Arterial phase of the same lesion following selective embolization.74 V. A. VISHNEVSKY ET AL.
indications were associated hematological and/or coagulation abnormalities in 5,
rapid increase in size in 2, hemobilia in 1 and pyrexia in 1. Surgical approach was
through right thoracophrenolaparotomy in 6 and bilateral subcostal in 10. Surgical
procedures included (Table 3) left lobectomies 7(43.75%), left lateral segmentec-
tomies 3(18.75%), right lobectomies 2(12.5%), right trisegmentectomies 2(12.5%)
(Figure 3a) and nonantomical resection of 2 to 3 segments in 2(12.5%). Two
patients required additional resection of 1 to 2 segments and in 3, small lesions of
2-3 cm size were left unexcised. In 13 cases with embolization, operative blood loss
ranged from 250 ml 2500 ml (mean 1146) and in 2, one with and other without
embolization (cases 15 and 16) the blood loss was massive- 18000 and 11000 ml
respectively, requiring the use of Haemonetics Cell-saver for autotransfusion of
6000 and 4000 ml of blood respectively. The hemangiomas appeared relatively less
turgid and shrinken in size following embolization. The resected specimen weighed
between 460 and 3200g (mean 980) and cut section showed central cavity in four
(Figure 3b). Histopathological examination confirmed the presence of cavernous
Figure 3(a). Intraoperative photograph of hemangioma (case 15). (b) Cut section showing typical
shrinkage of the lesion and large central area of hyalinization and cavitation.GIANT CAVERNOUS HEMANGIOMA LIVER 75
Table 3 Details of the lesion and operative procedure.
Case No. Maximum Hepatic
dimension Segments
(cm)




















II-IV + 850 Left lobectomy
II-IV + 700 Left lobectomy
II-IV + 1500 Left lobectomy
II-IV + 1500 Left lobectomy
II, III + 1000 Left lobectomy
II, III + 1100 Left lobectomy
IV, V Resection of Seg V
II-VI + 2500 Left lobectomy
Resection of Seg V, VI
II, III + 500 Lt. lateral
segmentectomy
II, III + 1000 Lt. lateral segmentectomy
II, III + 250 Lt. lateral segmentectomy
IV-VI + 1000 Resection of seg IV-VI
V, VI + 500 Resection of seg V, VI
V-VIII + 2500 Rt. trisegmentectomy
IV
V-VIII 2000 Right lobectomy
IV-VIII + 18000 Rt. trisegmentectomy
V-VIII 11000 Right lobectomy76 V.A. VISHNEVSKY ET AL.
hemangioma of the liver. Postoperative complications developed in 4 (25%)-
subdiaphragmatic fluid collection in 2, peritonitis in 1 and early post-operative
hemorrhage in 1 latter two required relaparotomy. There were no operative
deaths, 14 cases were followed from 6-45 months (mean 18) and remain symptom
free.
DISCUSSION
Cavernous hemangioma is the most common benign tumor of the liver occurring
more frequently in females in the fourth decade of life 11,12. Age and sex of our study
match with that reported in the literature. The clinical features of hepatic heman-
gioma are not characteristic of liver tumors7. Lesions measuring more than 4cm in
diameter are known as giant hemangiomas because such lesions are often
symptomatic13. In a series of 16 cases of cavernous hemangioma of liver reported by
Schwartz and Husser, the mean size of operated lesion was 10cm with 50% of them
palpable on clinical examination. Iwatsuki et a112 reported 109 operated cases of
hepatic hemangiomas with mean size of 12cm and abdominal pain was a common
symptom noted in 45% of cases. Hematological, biochemical and coagulation
abnormalities although rare, are reported with these lesions- the Kasabach-Merritt
syndrome14, consisting of anemia, thrombocytopenia, primary fibrinolysis
12 and
reactive hypoglycemia1. On ultrasonographic examination larger hemangiomas
measuring more than 8cm produce an heterogenic echo pattern1’5. CT is more
accurate in diagnosis of such lesions showing low dense area in pre-contrast scans
and characteristic enhancement from periphery to centre of hemangioma on post-
contrast dynamic scanningTM. MRI is the latest contribution to liver imaging
having an accuracy of nearly 90% in diagnosis of hepatic hemangiomas17. T2
weighed images by MRI are characteristic and help to differentiate hemangiomas
of liver from other hypervascular tumors like hepatocellular carcinomaTM. Hepatic
angiography has a diagnostic accuracy of 100%
19 but, since it is invasive, it is being
replaced by noninvasive and equally informative multi-modal imaging techniques-
US, CT and MRI5-1. Although severe bleeding has occurred following needle
aspiration biopsy,6’8’2 successful diagnostic use of FNAC has been reported in 15
cases of cavernous hemangioma of the liver without any complication21. None of
our 11 cases experienced any complication following FNAC but its diagnostic yield
was 64%. Following therapeutic hepatic artery embolization for benign hepatic
tumors including hemangiomas, complications like tumor liquitication, abscess
formation and emboli migration are reported9’1. Two of our cases developed
hypofibrinogenemia following embolization and one (case 16) had thrombocytope-
nia, hypofibrinogenemia and a low prothrombin index after angiography. We
believe that embolization, if carried out alone is not the effective method of
treatment of large symptomatic cavernous hemangiomas, as the disease per se is not
eradicated and the chances of tumor necrosis and abscess formation are high.
Surgery is the treatment of choice for giant cavernous hemangiomas7’124"2
because the majority of such lesions are symptomatic. Thirteen of 16 (81%)
operated giant cavernous hemangiomas reported by Schwartz and Husser had pain
and/or mass. Similarly 18 of 22 (82%) operated cases reported by Adam et al.
3
were noted to have various abdominal symptoms including spontaneous rupture.
Although the potential for rupture of these lesions is minimal- 1 to 3% ..23, theGIANT CAVERNOUS HEMANGIOMA LIVER 77
rupture either spontaneous or induced by trivial trauma is associated even in the
present day with high mortality13’22’24. Rapid increase in their size has been
reported7’13. Cavernous hemangiomas pose special problems during liver resection
because of their vascular nature. In Starzl’s series of 15 operated cases2, the
average blood loss was 1700ml and Schwartz in his 16 resected cases of hepatic
hemangiomas noted on average blood loss of 1750 ml7. Of our 14 cases with
preoperative selective hepatic artery embolization, 13 major hepatic resections
were associated with an average blood loss of 1146 ml. Although our study lacks a
control group without embolization, our case material is comparable with that of
previous authors7’2. Size of operated lesion is larger in our cases (mean 19cm versus
10cm) and operative blood loss is less (mean 1146 ml versus 1750 ml). But in two
cases including one with embolization (case 15 and 16), profuse retrograde venous
bleeding occurred during right lobectomy in one and right trisegmentectomy in the
other, probably due to the presence of arteriovenous communications within the
lesion. In each of these cases huge right lobe hemangioma added technical difficulty
to gain access to the right hepatic vein. Starzl et al.
25 reported a similar case of giant
hepatic hemangioma with arteriovenous malformation which led to massive blood
loss of 20,000 ml during left trisegmentectomy with successful outcome. In our two
cases massive intraoperative hemorrhage was replaced by autotransfusion of blood
from operating field with the help of Cell-saver and fresh donor blood and plasma
transfusion. Routine use of Cell-saver is described by Schwartz during hepatic
resections for benign lesions including hemangiomas.
In conclusion, giant symptomatic hepatic hemangiomas, unlike other benign
tumors of liver pose problems of increased bleeding during hepatic resection
because of their vascular nature and they are better operated on in specialized
surgical centres that routinely perform hepatic surgery. Preoperative selective
hepatic artery embolization helps to decrease intraoperative bleeding in the
majority. However, in cases of severe bleeding presence of adequate blood reserve
and use of Cell-saver can help tide over the crisis.
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INVITED COMMENTARY
The authors are to be congratulated for the zero operative mortality achieved in
these 16 hepatic resections done for giant cavernous hemangiomas (all measured 15
cm or more in diameter). This study supports the current contention that major
hepatic resections should today be performed with an acceptably low mortality and
morbidity.
The authors suggest a multimodality diagnostic approach when hepatic heman-
giomata are suspected. This approach includes a variety of invasive (angiography)
and noninvasive (ultrasonography) radiological techniques as well as fine needle
aspiration biopsy. The latter is certainly controversialmdespite the lack of compli-
cations following FNA in this series, wide application should be cautioned. The
authors do not suggest which investigation they prefer or in which sequence. In this
study, the sensitivity for computerized tomography was 82%. Although they state
that all patients in their study were symptomatic--the manuscript suggests that
these symptoms were minimal in nature which would be in keeping with most
reported series.
Of particular interest is the suggestion that routine preoperative selective hepatic
artery embolization should be performed since it might decrease operative blood
loss. This is based on the nonrandomized comparison of 14 patients who underwent
preoperative embolization, to two patients who did not. As the authors themselvesGIANT CAVERNOUS HEMANGIOMA LIVER 79
are quick to point out, such a comparison is not valid. It is hoped that they might
consider randomization of their patients in the future, thus providing us with
extremely valuable information. It has been our experience that blood loss during
hepatic resections for cavernous hemangiomas is often minimal and that the "bad
reputation" that these fascinating vascular tumors have is probably unjustified.
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